Impact of ruxolitinib on survival of patients with myelofibrosis in the real world: update of the ERNEST Study

Detalles Bibliográficos
Autores principales: Guglielmelli, Paola, Ghirardi, Arianna, Carobbio, Alessandra, Masciulli, Arianna, Maccari, Chiara, Mora, Barbara, Rumi, Elisa, Triguero, Ana, Finazzi, Maria Chiara, Pettersson, Helna, Paoli, Chiara, Mannelli, Francesco, Vanni, Daniele, Rambaldi, Alessandro, Passamonti, Francesco, Alvarez-Larràn, Alberto, Andreasson, Bjorn, Vannucchi, Alessandro M., Barbui, Tiziano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791590/
https://www.ncbi.nlm.nih.gov/pubmed/34753179
http://dx.doi.org/10.1182/bloodadvances.2021006006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791590/
https://www.ncbi.nlm.nih.gov/pubmed/34753179
http://dx.doi.org/10.1182/bloodadvances.2021006006

Ejemplares similares